A phase II pilot trial investigating the efficacy and activity of single agent granulocyte macrophage colony-stimulating factor as maintenance approach in castration - resistant prostate cancer patients responding to chemotherapy

Purpose: To investigate the toxicity and efficacy of GM-CSF in castration-resistant prostate cancer (CRPC) patients who maximized their response to systemic chemotherapy. Materials and Methods: CRPC patients who maximized their response to either docetaxel or mitoxantrone chemotherapy were eligible...

Full description

Saved in:
Bibliographic Details
Main Authors: Chadi Nabhan, Andrew Meyer, Kathy Tolzien, Jacob D Bitran, Timothy M Lestingi
Format: article
Language:EN
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2011
Subjects:
R
Online Access:https://doaj.org/article/7da2de9150f640a6818140361796f919
Tags: Add Tag
No Tags, Be the first to tag this record!